{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:42:03Z","timestamp":1776260523467,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005611","name":"University of Fukui","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005611","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.bcp.2014.04.002","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T07:46:07Z","timestamp":1397375167000},"page":"16-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["G\u00f66976, a FLT3 kinase inhibitor, exerts potent cytotoxic activity against acute leukemia via inhibition of survivin and MCL-1"],"prefix":"10.1016","volume":"90","author":[{"given":"Akira","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Ookura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Zokumasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2014.04.002_bib0005","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1038\/sj.onc.1207456","article-title":"FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins","volume":"23","author":"Scheijen","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2014.04.002_bib0010","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1080\/1042819021000002866","article-title":"FLT3 in human hematologic malignancies","volume":"43","author":"Kiyoi","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2014.04.002_bib0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2014.04.002_bib0020","first-page":"190","article-title":"FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group","volume":"111","author":"Abu-Duhier","year":"2000","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0025","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.leu.2404246","article-title":"Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples","volume":"20","author":"Cloos","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2014.04.002_bib0030","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.onc.1203354","article-title":"Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines","volume":"19","author":"Hayakawa","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2014.04.002_bib0035","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/carcin\/bgl035","article-title":"Carcinogenesis and apoptosis: paradigms and paradoxes","volume":"27","author":"Zhivotovsky","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2014.04.002_bib0040","doi-asserted-by":"crossref","first-page":"24882","DOI":"10.1074\/jbc.M111.255828","article-title":"Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA","volume":"286","author":"Albershardt","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.04.002_bib0045","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2008-11-188714","article-title":"Survivin mediates aberrant hematopoietic progenitor cell proliferation and acute leukemia in mice induced by internal tandem duplication of Flt3","volume":"114","author":"Fukuda","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0050","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1182\/blood-2008-12-196055","article-title":"FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation","volume":"114","author":"Yoshimoto","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0055","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1182\/blood-2010-04-261867","article-title":"FLT3 as a therapeutic target in AML: still challenging after all these years","volume":"116","author":"Kindler","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0060","first-page":"429","article-title":"FLT3 inhibitors for the treatment of acute myeloid leukemia","volume":"8","author":"Wiernik","year":"2010","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0065","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bcp.2010.08.002","article-title":"Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia","volume":"80","author":"Eriksson","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0070","first-page":"5465","article-title":"An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients","volume":"9","author":"O\u2018Farrell","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.002_bib0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.leu.2404508","article-title":"Antitumor activity of sorafenib in FLT3-driven leukemic cells","volume":"21","author":"Auclair","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2014.04.002_bib0080","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(02)00070-3","article-title":"CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)","volume":"1","author":"Kelly","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2014.04.002_bib0085","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1182\/blood-2008-09-177030","article-title":"A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response","volume":"113","author":"Pratz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0090","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1182\/blood-2006-06-029579","article-title":"ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia","volume":"109","author":"Shankar","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0095","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/138945010791320782","article-title":"Bench to bedside targeting of FLT3 in acute leukemia","volume":"11","author":"Pratz","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.bcp.2014.04.002_bib0100","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1200\/JCO.2013.48.8783","article-title":"Study of quizartinib administered daily to patients with relapsed or refractory acute myeloid leukemia irrespective of FMS-like tyrosine kinase 3-internal tandem duplication status","volume":"31","author":"Cortes","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0105","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1073\/pnas.90.10.4674","article-title":"Go 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent\/low-level-producing reservoir cells in vitro","volume":"90","author":"Qatsha","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.04.002_bib0110","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1016\/S0021-9258(18)98335-3","article-title":"Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976","volume":"268","author":"Martiny-Baron","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.04.002_bib0115","first-page":"31","article-title":"The protein kinase C inhibitor Go6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints","volume":"63","author":"Kohn","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.002_bib0120","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1476-5381.2011.01449.x","article-title":"Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-kappaB and STAT3 regulated gene products in multiple myeloma cells","volume":"164","author":"Kannaiyan","year":"2011","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1476-5381.2010.01187.x","article-title":"gamma-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent","volume":"163","author":"Rajendran","year":"2011","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0130","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1182\/blood-2008-05-156422","article-title":"Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML","volume":"113","author":"Zhou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3324\/haematol.2011.046466","article-title":"Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells","volume":"97","author":"Jacquemin","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2014.04.002_bib0140","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1182\/blood-2006-04-015743","article-title":"Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors","volume":"108","author":"Levis","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOH.0b013e3283439a03","article-title":"FLT3 inhibitors: a story of the old and the new","volume":"18","author":"Fathi","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0150","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1073\/pnas.1005847107","article-title":"Phosphorylation stabilizes Nanog by promoting its interaction with Pin1","volume":"107","author":"Moretto-Zita","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.04.002_bib0155","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0160","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/sj.onc.1207606","article-title":"STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells","volume":"23","author":"Kanda","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2014.04.002_bib0165","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood.V91.3.991","article-title":"Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse","volume":"91","author":"Kaufmann","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0170","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1038\/bcj.2012.5","article-title":"Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies","volume":"2","author":"Kasper","year":"2012","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.bcp.2014.04.002_bib0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1101\/gad.182980.111","article-title":"Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia","volume":"26","author":"Glaser","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2014.04.002_bib0180","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1158\/0008-5472.CAN-08-0579","article-title":"Down-regulation of myeloid cell leukemia-1 through inhibiting Erk\/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer","volume":"68","author":"Ding","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2014.04.002_bib0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2006.06291.x","article-title":"Go6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells","volume":"135","author":"Grandage","year":"2006","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0190","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2014.04.002_bib0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2014.04.002_bib0200","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2002-07-2130","article-title":"Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma","volume":"101","author":"Aoki","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0205","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1073\/pnas.0600181104","article-title":"Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis","volume":"104","author":"Conway-Campbell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.04.002_bib0210","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.1106114","article-title":"Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells","volume":"307","author":"Opferman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bcp.2014.04.002_bib0215","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1","volume":"426","author":"Opferman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2014.04.002_bib0220","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1038\/sj.onc.1206028","article-title":"Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells","volume":"21","author":"Huang","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2014.04.002_bib0225","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/MCB.23.6.1896-1909.2003","article-title":"Interleukin-3 stimulation of mcl-1 gene transcription involves activation of the PU.1 transcription factor through a p38 mitogen-activated protein kinase-dependent pathway","volume":"23","author":"Wang","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2014.04.002_bib0230","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI9940","article-title":"Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression","volume":"107","author":"Epling-Burnette","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2014.04.002_bib0235","doi-asserted-by":"crossref","first-page":"26915","DOI":"10.1074\/jbc.M313875200","article-title":"Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1","volume":"279","author":"Derouet","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.04.002_bib0240","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood-2010-01-262808","article-title":"Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2014.04.002_bib0245","doi-asserted-by":"crossref","first-page":"35217","DOI":"10.1074\/jbc.M506551200","article-title":"Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation","volume":"280","author":"Rahmani","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.04.002_bib0250","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1158\/1535-7163.MCT-10-0028","article-title":"Vinblastine induces acute, cell cycle phase-independent apoptosis in some leukemias and lymphomas and can induce acute apoptosis in others when Mcl-1 is suppressed","volume":"9","author":"Salerni","year":"2010","journal-title":"Mol Cancer Therapeut"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214002263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214002263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:58:26Z","timestamp":1757768306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214002263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0006295214002263"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.04.002","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G\u00f66976, a FLT3 kinase inhibitor, exerts potent cytotoxic activity against acute leukemia via inhibition of survivin and MCL-1","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}